0000899243-21-008412.txt : 20210226 0000899243-21-008412.hdr.sgml : 20210226 20210226162348 ACCESSION NUMBER: 0000899243-21-008412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sperzel John J III CENTRAL INDEX KEY: 0001602618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 21689239 MAIL ADDRESS: STREET 1: 61 CRESTVIEW LANE CITY: BRUNSWICK STATE: ME ZIP: 04011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-24 0 0001492674 T2 Biosystems, Inc. TTOO 0001602618 Sperzel John J III 101 HARTWELL AVENUE LEXINGTON MA 02421 1 1 0 0 See Remarks Restricted Stock Units 2021-02-24 4 A 0 1693989 0.00 A Common Stock 1693989 1693989 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in three equal annual installments commencing on February 24, 2022. President and Chief Executive Officer /s/ John Sprague, Attorney-in-fact 2021-02-26